Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

NCT04321174 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04321174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04321174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
Lead sponsor
Unity Health Toronto
Phase
Phase 3
Overall status
Unknown status
Start date
April 17, 2020
Completion date
March 31, 2022
Enrollment
123 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infections, post-exposure prophylaxis